Annie Baker on Muck Rack

Annie Baker

Verified
Ypsilanti
As seen in: Pulse 2.0, BiggerPockets, The Wealth Advisor
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Annie

Contact Annie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

2538 Saint Lawrence Dr, San Jose, CA 95124, US

|
By Annie Baker Verified
| BiggerPockets Verified
Operating Expenses Recurring costs required to maintain and manage a rental property, including property taxes, insurance, maintenance, repairs, utilities (if paid by the owner), property management fees, and other day-to-day expenses. Calculation: Insurance + Property Taxes + Property Management + Repairs & Maintenance + Capital Expenditures + HOA Fees
Open in Who Shared View Duplicates (677) Issue with article?

Marqo: Vector Search Company Raises $12.5 Million

|
By Annie Baker Verified
| Pulse 2.0 Verified
Vector search company Marqo announced it had closed a $12.5 million Series A funding round led by Lightspeed with participation from Blackbird VC, January Capital, and Chronosphere founder and CTO Rob Skillington. This funding round will advance the adoption of its next-generation search platform, unlocking the massive value of unstructured data across business-critical applications like end-user search, retrieval-augmented generation, etc.
Open in Who Shared Issue with article?

Areteia Therapeutics: $75 Million Raised To Expand Current Phase III Development Of Dexpramipexole In Eosinophilic Asthma

|
By Annie Baker Verified
| Pulse 2.0 Verified
Areteia Therapeutics announced $75 million in additional Series A financing to support expansion of the current Phase III development program of dexpramipexole in eosinophilic asthma, bringing total Series A funding to $425 million. Viking Global Investors and Marshall Wace joined the original syndicate of investors led by Bain Capital Life Sciences with participation from Access Biotechnology, GV, ARCH Venture Partners, Saturn Partners, Sanofi, Maverick Capital, and Population Health Partners.
Open in Who Shared Issue with article?
See all 2,109 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified